EF Hutton Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
Go back to EF Hutton Reiterates Buy Rating on Enlivex Therapeutics (ENLV)| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 1.73 +0.21 (13.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.52 | 52 Week High | $0.94 | |||
| Open | $1.50 | 52 Week Low | $0.47 | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.47 | EPS | $-0.11 | |||
| Volume | 294,675 | |||||
